Literature DB >> 18821935

A case of heterogeneous breast cancer with clonally expanded T-Cells in the HER2+ and metastasis of the HER2- tumor cells.

Thorsten Wiech1, Elisabeth Nikolopoulos, Michael Hausmann, Axel Walch, Martin Werner, Paul Fisch.   

Abstract

We report a case of an invasive ductal breast carcinoma with significant heterogeneity: a HER-2+ tumor component was densely infiltrated by T-cells, whereas the HER2- tumor component, including two axillary lymph node metastases, showed much fewer tumor infiltrating lymphocytes. Array comparative genomic hybridization of dissected tumor cells from both components revealed many shared chromosomal aberrations but also unique alterations of the HER2+ tumor cell population besides HER2 amplification. We found a clonally dominated T-cell receptor rearrangement of the tumor infiltrating lymphocytes in the HER2+, but not in the HER2- tumor component. Thus, in this case HER2 overexpression is associated with a marked infiltration by T-cells suggesting a specific T-cell response against the HER2+ tumor cell population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821935     DOI: 10.1111/j.1524-4741.2008.00627.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Localization microscopy reveals expression-dependent parameters of chromatin nanostructure.

Authors:  Manfred Bohn; Philipp Diesinger; Rainer Kaufmann; Yanina Weiland; Patrick Müller; Manuel Gunkel; Alexa von Ketteler; Paul Lemmer; Michael Hausmann; Dieter W Heermann; Christoph Cremer
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

2.  Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Authors:  Anna M Sherwood; Ryan O Emerson; Dominique Scherer; Nina Habermann; Katharina Buck; Jürgen Staffa; Cindy Desmarais; Niels Halama; Dirk Jaeger; Peter Schirmacher; Esther Herpel; Matthias Kloor; Alexis Ulrich; Martin Schneider; Cornelia M Ulrich; Harlan Robins
Journal:  Cancer Immunol Immunother       Date:  2013-06-16       Impact factor: 6.968

3.  Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes.

Authors:  M Stumpf; A Hasenburg; M-O Riener; U Jütting; C Wang; Y Shen; M Orlowska-Volk; P Fisch; Z Wang; G Gitsch; M Werner; S Lassmann
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

4.  Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles.

Authors:  Yi Zhao; Daria Y Alakhova; Xiangshan Zhao; Vimla Band; Elena V Batrakova; Alexander V Kabanov
Journal:  Nanomedicine       Date:  2019-11-20       Impact factor: 6.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.